ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: SA-PO643

A Nephrologist-Driven Percutaneous Peritoneal Dialysis Catheter Insertion Service Increases the Prevalence of Peritoneal Dialysis: A Single-Centre Experience in Singapore

Session Information

  • Home Dialysis - II
    November 04, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 802 Dialysis: Home Dialysis and Peritoneal Dialysis


  • Koduri, Sreekanth, Changi General Hospital, Singapore, Singapore, Singapore

The incidence and prevalence of end stage kidney disease(ESKD) requiring dialysis is increasing all over world, including Singapore. Despite the well documented benefits of peritoneal dialysis(PD) in offering better quailty of life and preservation of residual renal function, only around 15% of prevalent ESKD patients are on PD in Singapore.
The aim of the study is to report the success of a percutaneous PD catheter insertion service in increasing the prevalence of PD in a large academic renal centre.


The number of prevalent PD patients was stagnant in our centre, over last 5years, despite the consistent growth in the number of ESKD patients requiring dialysis during this period. From early 2022, the interventional nephrologists started a percutaneous PD catheter insertion service. Based pre-determined criteria, the patients were selected for appropriate method of PD catheter insertion by the nephrologists, as illustrated in figure 1.


Since 2022, 75.9% of the PD catheters were inserted percutaneously by interventional nephrologists. The complication rates were very low with no episodes of bowel perforation, major bleeding or PD peritonitis within 2weeks of catheter insertion. There was one episode (1.5%) of exit site infection within 2weeks of catheter insertion. Since the introduction of this service, the number of prevalent PD patients increased by 55% by May 2023 when compared to December 2021(104 vs 67prevalent patients), as illustrated in figure 2.


Percutaneous PD catheter insertion by nephrologists, with appropriate selection of patients, is safe and reliable. This service provides timely access creation and increases the penetration of PD.

Figure 2

Figure 1